The estimated Net Worth of Associates Vi, L.P.Venrock ... is at least $108 Milhão dollars as of 20 May 2020. Associates Venrock owns over 1,013,569 units of 10x Genomics stock worth over $28,460,933 and over the last 5 years Associates sold TXG stock worth over $79,058,382.
Associates has made over 1 trades of the 10x Genomics stock since 2020, according to the Form 4 filled with the SEC. Most recently Associates sold 1,013,569 units of TXG stock worth $79,058,382 on 20 May 2020.
The largest trade Associates's ever made was selling 1,013,569 units of 10x Genomics stock on 20 May 2020 worth over $79,058,382. On average, Associates trades about 202,714 units every 0 days since 2019. As of 20 May 2020 Associates still owns at least 1,287,825 units of 10x Genomics stock.
You can see the complete history of Associates Venrock stock trades at the bottom of the page.
Over the last 5 years, insiders at 10x Genomics have traded over $629,686,183 worth of 10x Genomics stock and bought 487,816 units worth $19,025,295 . The most active insiders traders include Bryan E Roberts, Capital Management I, Llc F..., eBenjamin J. Hindson. On average, 10x Genomics executives and independent directors trade stock every 8 days with the average trade being worth of $1,002,346. The most recent stock trade was executed by Serge Saxonov on 22 August 2024, trading 6,749 units of TXG stock currently worth $152,055.
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
10x Genomics executives and other stock owners filed with the SEC include: